10x Genomics Inc
TXG
Company Profile
Business description
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Contact
6230 Stoneridge Mall Road
PleasantonCA94588
USAT: +1 925 401-7300
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2025
Employees
1,259
Stocks News & Analysis
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
Shockwaves from Monday's AI stock panic in the US were largely confined to two ASX industries.
video
What does a weak Aussie dollar mean for investors?
Morningstar Investment Management's Chief Investment Officer for Asia Pacific weighs in on the weak Aussie dollar and what this could mean for investors.
stocks
AI stock rout: The US selloff in 4 charts
Worries about Western AI dominance permeated the markets, with Nvidia stock plunging 17% alongside other chipmakers, utilities, and more.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,745.90 | 45.20 | 0.52% |
| CAC 40 | 7,932.42 | 59.94 | 0.76% |
| DAX 40 | 21,694.20 | 56.67 | 0.26% |
| Dow JONES (US) | 44,845.50 | 131.98 | 0.30% |
| FTSE 100 | 8,614.75 | 56.94 | 0.67% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,765.64 | 133.32 | 0.68% |
| Nikkei 225 | 39,513.97 | 99.19 | 0.25% |
| NZX 50 Index | 12,928.38 | 74.66 | -0.57% |
| S&P 500 | 6,077.03 | 37.72 | 0.62% |
| S&P/ASX 200 | 8,493.70 | 46.70 | 0.55% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |